Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States
Related Posts
Duberstein ZT, Murphy H, Wu Q, Meng Y, Wang C, Smith R, Salafia C, Chowdhury SF, Barrett E, Scheible K, Qiu X, O'Connor TG. Do[...]
Wojcik G, Arvanitis M, Haberlen S, Kim EY, Kim H, Nam K, Feinstein MJ, Wolinsky S, Margolick JB, Budoff M, Magnani JW, Duggal P, Post[...]
Tantisattamo E, Rattanasompattikul M, Traitanon O, Eguchi N, Ichii H, Kantachuvesiri S, Kalantar-Zadeh K. Enhancing accuracy and adherence in blood pressure monitoring in living kidney[...]